Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research impact assessment of a Canadian digital health funding program: a case study.

Health research policy and systems·2025
Same author

The rise of health biotechnology research in Latin America: A scientometric analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico.

PloS one·2018
Same author

Corporate social responsibility to improve access to medicines: the case of Brazil.

Globalization and health·2017
Same author

Canada's neglected tropical disease research network: who's in the core-who's on the periphery?

PLoS neglected tropical diseases·2013
Same author

Sino-Canadian collaborations in stem cell research: a scientometric analysis.

PloS one·2013
Same author

History of science. Tackling meningitis in Africa.

Science (New York, N.Y.)·2012

Related Experiment Video

Updated: May 28, 2026

Counting Human Neural Stem Cells
06:37

Counting Human Neural Stem Cells

Published on: August 22, 2007

Making stem cells count for global health.

Dominique S McMahon1, Halla Thorsteinsdóttir

  • 1Dalla Lana School of Public Health, University of Toronto, Ontario, M5T 3M7, Canada. dominique.mcmahon@utoronto.ca

Regenerative Medicine
|October 18, 2011
PubMed
Summary
This summary is machine-generated.

Developing countries investing in stem cell research need local involvement to ensure products are relevant and affordable. Stem cell therapies require better oversight and access measures for equitable global health impact.

More Related Videos

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
07:01

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells
07:14

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells

Published on: May 17, 2021

Related Experiment Videos

Last Updated: May 28, 2026

Counting Human Neural Stem Cells
06:37

Counting Human Neural Stem Cells

Published on: August 22, 2007

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
07:01

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells
07:14

A Culture Method to Maintain Quiescent Human Hematopoietic Stem Cells

Published on: May 17, 2021

Area of Science:

  • Biomedical research
  • Regenerative medicine
  • Global health policy

Background:

  • Developing nations like China, India, and Brazil are significantly increasing investments in stem cell research and therapies.
  • The global stem cell market is expanding, with emerging economies playing a crucial role in its growth and direction.

Purpose of the Study:

  • To analyze the necessity of direct involvement by developing countries in stem cell research.
  • To examine the potential challenges and requirements for stem cell therapies to achieve equitable global health benefits.

Main Methods:

  • This study presents an argumentative analysis based on current trends in stem cell research and investment.
  • It synthesizes information on the economic and ethical considerations of stem cell technology adoption in developing countries.

Main Results:

  • Hands-on involvement by developing countries is crucial for creating stem cell products that are locally relevant, affordable, and appropriate.
  • Stem cell research represents a high-risk investment with potential global health impacts that are likely distant.
  • Successful stem cell therapies will necessitate enhanced clinical oversight and robust measures to ensure equitable patient access.

Conclusions:

  • Local engagement in stem cell research is vital for developing countries to harness the technology effectively.
  • Addressing risks, ensuring clinical oversight, and promoting access are paramount for stem cell therapies to yield substantial and equitable global health outcomes.